Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models

Bibliographic Details
Main Authors: He, Li-Zhen, Thomas, Lawrence J, Testa, James, Weidlick, Jeffrey, Sisson, Crystal, Hammond, Russell, Vitale, Laura, Marsh, Henry, Keler, Tibor
Format: Online
Language:English
Published: BioMed Central 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990982/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990982/

Similar Items